{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:28:58Z","timestamp":1783384138335,"version":"3.54.6"},"reference-count":17,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>In women, radical cystectomy includes removal of the bladder, uterus, fallopian tubes, ovaries, and anterior vaginal wall, yet contiguous extension of urothelial carcinoma to all pelvic organs is rare and routine removal may be unnecessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To study pelvic organ involvement in women at radical cystectomy and investigate oncologic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Women with bladder cancer who underwent radical cystectomy at the Mayo Clinic and University of Toronto (1980\u20132018) were evaluated. Cancer-specific survival (CSS) was estimated with the Kaplan-Meier method; comparisons were made with the log-rank test. Associations with CSS were evaluated with Cox proportional hazard modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>A total of 70 women with pT4a and 83 with pT3b cancer were studied. Organs involved were vagina (n = 41 of 70; 58.6%), uterus (n = 26 of 54; 48.1%), cervix (n = 15 of 54; 27.8%), fallopian tubes (n = 10 of 58; 17.2%), and ovaries (n = 7 of 58; 12.1%); 22 of 58 patients (37.9%) had &amp;gt;1 organ involved. Of 70 with pT4a cancer, 64 were available for survival analysis by 3 pelvic organ groups: vaginal only, vaginal and\/or cervical\/uterine, and vaginal and\/or cervical\/uterine and\/or fallopian tubes\/ovarian involvement. Three-year CSS for vaginal involvement only was 39%; it was 14% if cervical\/uterine involvement, and &amp;lt;1% if fallopian tube\/ovarian involvement was included (P = .02). Among 20 women with pT4aN0\/Nx and vaginal involvement only, 3-year CSS for vaginal involvement was 50%, whereas among 48 women with pT3bN0\/Nx cancer, 3-year CSS was 58%, P = .70.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Isolated vaginal involvement should be separated from uterine and\/or adnexal extension of urothelial carcinoma at pathologic staging. Direct ovarian extension is rare and routine removal may be unnecessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2021-0409-oa","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T17:35:12Z","timestamp":1655228112000},"page":"202-207","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy"],"prefix":"10.5858","volume":"147","author":[{"given":"Svetlana","family":"Avulova","sequence":"first","affiliation":[{"name":"From the Division of Urology, Department of Surgery, Albany Medical Center, Albany, New York (Avulova)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Benidir","sequence":"additional","affiliation":[{"name":"From the Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio (Benidir)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Cheville), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh T.","family":"Packiam","sequence":"additional","affiliation":[{"name":"From the Department of Urology, University of Iowa, Iowa City (Packiam)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Shah","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Frank","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Tollefson","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabin","family":"Thapa","sequence":"additional","affiliation":[{"name":"From the Department of Health Sciences (Thapa), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Division of Urology, University of Toronto, Toronto, Ontario, Canada (Kulkarni)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[{"name":"From the Department of Urology (Shah, Frank, Tollefson, Thompson, Karnes, Boorjian), Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2023012621172360600_i1543-2165-147-2-202-b01","doi-asserted-by":"crossref","unstructured":"Siegel\n              RL\n            ,\n\t\t\t\t\t\tMillerKD,\n\t\t\t\t\t\tFuchsHE,\n\t\t\t\t\t\tJemalA.\n\t\t\t\t\t\n          Cancer statistics, 2021.\n\t\t\t\t\tCA Cancer J Clin.\n\t\t\t\t\t2021;71(1):7\u201333.\n\t\t\t\t\tdoi:10.3322\/caac.21654","DOI":"10.3322\/caac.21654"},{"key":"2023012621172360600_i1543-2165-147-2-202-b02","doi-asserted-by":"crossref","unstructured":"Williams\n              SB\n            ,\n\t\t\t\t\t\tHuoJ,\n\t\t\t\t\t\tDafashyTJ,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Survival differences among patients with bladder cancer according to sex: critical evaluation of radical cystectomy use and delay to treatment.\n\t\t\t\t\tUrol Oncol.\n\t\t\t\t\t2017;35(10):602.e1\u2013602.e9.\n\t\t\t\t\tdoi:10.1016\/j.urolonc.2017.05.022","DOI":"10.1016\/j.urolonc.2017.05.022"},{"key":"2023012621172360600_i1543-2165-147-2-202-b03","doi-asserted-by":"crossref","unstructured":"John\n              JB\n            ,\n\t\t\t\t\t\tVarugheseMA,\n\t\t\t\t\t\tCooperN,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Treatment allocation and survival in patients diagnosed with nonmetastatic muscle-invasive bladder cancer: an analysis of a national patient cohort in England.\n\t\t\t\t\tEur Urol Focus.\n\t\t\t\t\t2020;19:\n\t\t\t\t\t19.\n\t\t\t\t\tdoi:10.1016\/j.euf.2020.01.013","DOI":"10.1016\/j.euf.2020.01.013"},{"key":"2023012621172360600_i1543-2165-147-2-202-b04","doi-asserted-by":"crossref","unstructured":"Andreassen\n              BK\n            ,\n\t\t\t\t\t\tGrimsrudTK,\n\t\t\t\t\t\tHaugES.\n\t\t\t\t\t\n          Bladder cancer survival: women better off in the long run.\n\t\t\t\t\tEur J Cancer.\n\t\t\t\t\t2018;95:\n\t\t\t\t\t52\u201358.\n\t\t\t\t\tdoi:10.1016\/j.ejca.2018.03.001","DOI":"10.1016\/j.ejca.2018.03.001"},{"key":"2023012621172360600_i1543-2165-147-2-202-b05","doi-asserted-by":"crossref","unstructured":"Patel\n              AR\n            ,\n\t\t\t\t\t\tCohnJA,\n\t\t\t\t\t\tAbd El LatifA,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.\n\t\t\t\t\tJ Urol.\n\t\t\t\t\t2013;189(1):53\u201358.\n\t\t\t\t\tdoi:10.1016\/j.juro.2012.09.006","DOI":"10.1016\/j.juro.2012.09.006"},{"key":"2023012621172360600_i1543-2165-147-2-202-b06","doi-asserted-by":"crossref","unstructured":"Parker\n              WH\n            ,\n\t\t\t\t\t\tBroderMS,\n\t\t\t\t\t\tChangE,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.\n\t\t\t\t\tObstet Gynecol.\n\t\t\t\t\t2009;113(5):1027\u20131037.\n\t\t\t\t\tdoi:10.1097\/AOG.0b013e3181a11c64","DOI":"10.1097\/AOG.0b013e3181a11c64"},{"key":"2023012621172360600_i1543-2165-147-2-202-b07","doi-asserted-by":"crossref","unstructured":"Abboud\n              MA\n            ,\n\t\t\t\t\t\tTophamAK,\n\t\t\t\t\t\tParkerDC,\n\t\t\t\t\t\tBurksHR,\n\t\t\t\t\t\tCooksonMS,\n\t\t\t\t\t\tPatelSG.\n\t\t\t\t\t\n          Risk of ovarian malignancy in patients undergoing radical cystectomy for bladder cancer.\n\t\t\t\t\tUrology.\n\t\t\t\t\t2019;123:\n\t\t\t\t\t181\u2013185.\n\t\t\t\t\tdoi:10.1016\/j.urology.2018.10.017","DOI":"10.1016\/j.urology.2018.10.017"},{"key":"2023012621172360600_i1543-2165-147-2-202-b08","doi-asserted-by":"crossref","unstructured":"Parker\n              WH\n            .\n\t\t\t\t\t\n          Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health.\n\t\t\t\t\tJ Minim Invasive Gynecol.\n\t\t\t\t\t2010;17(2):161\u2013166.\n\t\t\t\t\tdoi:10.1016\/j.jmig.2009.12.016","DOI":"10.1016\/j.jmig.2009.12.016"},{"key":"2023012621172360600_i1543-2165-147-2-202-b09","doi-asserted-by":"crossref","unstructured":"Chang\n              SS\n            ,\n\t\t\t\t\t\tColeE,\n\t\t\t\t\t\tSmithJAJr,CooksonMS.\n\t\t\t\t\t\n          Pathological findings of gynecologic organs obtained at female radical cystectomy.\n\t\t\t\t\tJ Urol.\n\t\t\t\t\t2002;168(1):147\u2013149.","DOI":"10.1016\/S0022-5347(05)64849-5"},{"key":"2023012621172360600_i1543-2165-147-2-202-b10","doi-asserted-by":"crossref","unstructured":"Djaladat\n              H\n            ,\n\t\t\t\t\t\tBruinsHM,\n\t\t\t\t\t\tMirandaG,\n\t\t\t\t\t\tCaiJ,\n\t\t\t\t\t\tSkinnerEC,\n\t\t\t\t\t\tDaneshmandS.\n\t\t\t\t\t\n          Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.\n\t\t\t\t\tJ Urol.\n\t\t\t\t\t2012;188(6):2134\u20132138.\n\t\t\t\t\tdoi:10.1016\/j.juro.2012.08.024","DOI":"10.1016\/j.juro.2012.08.024"},{"key":"2023012621172360600_i1543-2165-147-2-202-b11","doi-asserted-by":"crossref","unstructured":"Gregg\n              JR\n            ,\n\t\t\t\t\t\tEmeruwaC,\n\t\t\t\t\t\tWongJ,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Oncologic outcomes after anterior exenteration for muscle invasive bladder cancer in women.\n\t\t\t\t\tJ Urol.\n\t\t\t\t\t2016;196(4):1030\u20131035.\n\t\t\t\t\tdoi:10.1016\/j.juro.2016.04.090","DOI":"10.1016\/j.juro.2016.04.090"},{"key":"2023012621172360600_i1543-2165-147-2-202-b12","doi-asserted-by":"crossref","unstructured":"Bree\n              KK\n            ,\n\t\t\t\t\t\tHensleyPJ,\n\t\t\t\t\t\tWestermanME,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Contemporary rates of gynecologic organ involvement in females with muscle invasive bladder cancer: a retrospective review of women undergoing radical cystectomy following neoadjuvant chemotherapy.\n\t\t\t\t\tJ Urol.\n\t\t\t\t\t2021;206(3):577\u2013585.\n\t\t\t\t\tdoi:10.1097\/JU.0000000000001784","DOI":"10.1097\/JU.0000000000001784"},{"key":"2023012621172360600_i1543-2165-147-2-202-b13","doi-asserted-by":"crossref","unstructured":"Weight\n              CJ\n            ,\n\t\t\t\t\t\tKimSP,\n\t\t\t\t\t\tLohseCM,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.\n\t\t\t\t\tEur Urol.\n\t\t\t\t\t2011;60(3):458\u2013464.\n\t\t\t\t\tdoi:10.1016\/j.eururo.2011.04.022","DOI":"10.1016\/j.eururo.2011.04.022"},{"key":"2023012621172360600_i1543-2165-147-2-202-b14","doi-asserted-by":"crossref","unstructured":"Liedberg\n              F\n            ,\n\t\t\t\t\t\tJanckeG,\n\t\t\t\t\t\tS\u00f6renbyA,\n\t\t\t\t\t\tKannistoP.\n\t\t\t\t\t\n          Should we refrain from performing oophorectomy in conjunction with radical cystectomy for bladder cancer?\n          \n            Eur Urol\n          .\n\t\t\t\t\t2017;71(6):851\u2013853.\n\t\t\t\t\tdoi:10.1016\/j.eururo.2016.10.010","DOI":"10.1016\/j.eururo.2016.10.010"},{"key":"2023012621172360600_i1543-2165-147-2-202-b15","doi-asserted-by":"crossref","unstructured":"Fogle\n              RH\n            ,\n\t\t\t\t\t\tStanczykFZ,\n\t\t\t\t\t\tZhangX,\n\t\t\t\t\t\tPaulsonRJ.\n\t\t\t\t\t\n          Ovarian androgen production in postmenopausal women.\n\t\t\t\t\tJ Clin Endocrinol Metab.\n\t\t\t\t\t2007;92(8):3040\u20133043.\n\t\t\t\t\tdoi:10.1210\/jc.2007-0581","DOI":"10.1210\/jc.2007-0581"},{"key":"2023012621172360600_i1543-2165-147-2-202-b16","doi-asserted-by":"crossref","unstructured":"Shifren\n              JL\n            ,\n\t\t\t\t\t\tBraunsteinGD,\n\t\t\t\t\t\tSimonJA,\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n          Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2000;343(10):682\u2013688.\n\t\t\t\t\tdoi:10.1056\/NEJM200009073431002","DOI":"10.1056\/NEJM200009073431002"},{"key":"2023012621172360600_i1543-2165-147-2-202-b17","doi-asserted-by":"crossref","unstructured":"Davis\n              SR\n            ,\n\t\t\t\t\t\tWorsleyR,\n\t\t\t\t\t\tMillerKK,\n\t\t\t\t\t\tParishSJ,\n\t\t\t\t\t\tSantoroN.\n\t\t\t\t\t\n          Androgens and female sexual function and dysfunction\u2013findings from the Fourth International Consultation of Sexual Medicine.\n\t\t\t\t\tJ Sex Med.\n\t\t\t\t\t2016;13(2):168\u2013178.\n\t\t\t\t\tdoi:10.1016\/j.jsxm.2015.12.033","DOI":"10.1016\/j.jsxm.2015.12.033"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/2\/202\/3183727\/i1543-2165-147-2-202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/2\/202\/3183727\/i1543-2165-147-2-202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:43Z","timestamp":1764790783000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/147\/2\/article-p202.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2021-0409-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}